Twin Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Twin Capital Management Inc

$853 Million
Q3 2024

A detailed history of Twin Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Twin Capital Management Inc holds 3,554 shares of REGN stock, worth $2.6 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,554

Previous 3,906 9.01%

Holding current value

$2.6 Million

Previous $4.11 Million 8.99%

% of portfolio

0.44%

Previous 0.5%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $360,479 - $423,019	-352 Reduced 9.01%	3,554 $3.74 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $105,100 - $127,471	119 Added 3.14%	3,906 $4.11 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $193,175 - $212,576	-214 Reduced 5.35%	3,787 $3.64 Million
Q4 2023 Jan 31, 2024	SELL	$775.18 - $881.7 $72,866 - $82,879	-94 Reduced 2.3%	4,001 $3.51 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $216,736 - $264,287	-313 Reduced 7.1%	4,095 $3.37 Million
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $161,006 - $190,980	-230 Reduced 4.96%	4,408 $3.17 Million
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $359,979 - $437,467	-529 Reduced 10.24%	4,638 $3.81 Million
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $168,707 - $183,167	-239 Reduced 4.42%	5,167 $3.73 Million
Q3 2022 Oct 21, 2022	SELL	$573.97 - $724.32 $44,195 - $55,772	-77 Reduced 1.4%	5,406 $3.72 Million
Q2 2022 Aug 02, 2022	BUY	$548.35 - $738.84 $180,407 - $243,078	329 Added 6.38%	5,483 $3.24 Million
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $17,258 - $20,254	29 Added 0.57%	5,154 $3.6 Million
Q4 2021 Feb 07, 2022	SELL	$543.48 - $670.97 $243,479 - $300,594	-448 Reduced 8.04%	5,125 $3.24 Million
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $332,363 - $394,275	-579 Reduced 9.41%	5,573 $3.37 Million
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $58,154 - $68,700	123 Added 2.04%	6,152 $3.44 Million
Q1 2021 May 06, 2021	SELL	$446.73 - $548.2 $370,339 - $454,457	-829 Reduced 12.09%	6,029 $2.85 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $210,452 - $267,511	440 Added 6.86%	6,858 $3.31 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $11,439 - $13,822	-21 Reduced 0.33%	6,418 $3.59 Million
Q2 2020 Aug 04, 2020	SELL	$493.32 - $643.92 $9,373 - $12,234	-19 Reduced 0.29%	6,439 $4.02 Million
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $57,150 - $84,053	-170 Reduced 2.56%	6,458 $3.15 Million
Q4 2019 Jan 29, 2020	BUY	$274.13 - $376.51 $1.42 Million - $1.95 Million	5,168 Added 353.97%	6,628 $2.49 Million
Q3 2019 Oct 28, 2019	SELL	$273.46 - $318.39 $13,672 - $15,919	-50 Reduced 3.31%	1,460 $405,000
Q2 2019 Aug 01, 2019	SELL	$299.6 - $414.82 $1.32 Million - $1.83 Million	-4,400 Reduced 74.45%	1,510 $473,000
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $2.2 Million - $2.6 Million	5,910 New	5,910 $2.43 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History